Joseph Petrosino, PhD
Chief Scientific Innovation Officer (CSIO), Baylor College of Medicine (BCM)
Joseph F. Petrosino, Ph.D. is the Chief Scientific Innovation Officer (CSIO) at Baylor College of Medicine (BCM), where he is also professor and chairman of the department of Molecular Virology and Microbiology, founding director of the Alkek Center for Metagenomics and Microbiome Research (CMMR) and a member of the Dan L. Duncan Comprehensive Cancer Center.
He received his Ph.D. from Baylor College of Medicine in 1998 and remained at Baylor for postdoctoral training in the Department of Molecular and Human Genetics until 2004 when he joined the faculty of the Department of Molecular Virology and Microbiology.
In 2013, Dr. Petrosino founded Diversigen, a start-up where the robust analytic pipelines built in the CMMR have been commercialized to support biotech and pharmaceutical industry needs. He sits on the scientific advisory boards of several biotechnology, pharmaceutical, and nutrition companies and has contributed to more than 290 peer-reviewed microbiome studies.
As the BCM CSIO, Dr. Petrosino leads the commercialization mission for the institution, directing the strategy for how therapeutic, diagnostic, educational, digital health, device, and other BCM intellectual property may be translated from the academic environment to the commercial realm.